The ROE as of November 2024 (TTM) for Bio-Path Holdings, Inc. (BPTH) is 2.62%

According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 2.62%. This represents a change of -2229.79% compared to the average of -123.02% of the last 4 quarters.

Bio-Path Holdings, Inc. (BPTH) Historical ROE (quarterly & annually)

How has BPTH ROE performed in the past?

The mean historical ROE of Bio-Path Holdings, Inc. over the last ten years is -485.64%. The current 2.62% ROE has changed -639.50% with respect to the historical average. Over the past ten years (40 quarters), BPTH's ROE was at its highest in in the September 2024 quarter at 297.05%. The ROE was at its lowest in in the December 2023 quarter at -764.63%.

Bio-Path Holdings, Inc. (BPTH) ROE by Quarter and Year

Discovering the peaks and valleys of Bio-Path Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Path Holdings, Inc. (BPTH) Average ROE

How has BPTH ROE performed in the past?

The current ROE of Bio-Path Holdings, Inc. (BPTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bio-Path Holdings, Inc. (BPTH) ROE vs. Peers

How is BPTH’s ROE compared to its peers?

Bio-Path Holdings, Inc.’s ROE is greater than Catalyst Biosciences, Inc. (-107.89%), greater than Diffusion Pharmaceuticals Inc. (0.31%), greater than Capricor Therapeutics, Inc. (-41648.68%), greater than NextCure, Inc. (-62.50%), greater than Pulmatrix, Inc. (-63.07%), greater than Bellerophon Therapeutics, Inc. (-151.06%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than Applied Molecular Transport Inc. (-131.59%), greater than Aileron Therapeutics, Inc. (-46.89%), greater than Benitec Biopharma Inc. (-60.28%), greater than Onconova Therapeutics, Inc. (-144.95%), greater than Moleculin Biotech, Inc. (-165.56%), greater than Achieve Life Sciences, Inc. (-108.30%), greater than Icosavax, Inc. (-20.22%), less than Akari Therapeutics, Plc (550.78%),

Build a custom stock screener for Bio-Path Holdings, Inc. (BPTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Path Holdings, Inc. (BPTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.